Development of Simulated Hippotherapy System and Investigation of Its Effectiveness in Children With Cerebral Palsy
Cerebral Palsy
About this trial
This is an interventional supportive care trial for Cerebral Palsy focused on measuring Cerebral Palsy, Physiotherapy and Rehabilitation, Hippotherapy, Balance
Eligibility Criteria
Inclusion Criteria
- Having a diagnosis of Spastic Cerebral Palsy,
- Children aged between 5 - 18 years,
- Gross motor functional level is I, II or III,
- Independent seating
- Walking at least 10 meters independently,
- Can understand simple verbal instructions,
- Those with a spasticity level less than 2 according to Modified Ashworth Scale ,
- Having bilateral hip abduction enough to sit on the hippotherapy device,
- Voluntary acceptance to participate in the study
Exclusion Criteria
- Having hip dislocation,
- Severe contracture or deformity,
- Scoliosis (above 20 degrees),
- Acute uncontrolled acute seizures,
- Epilepsy,
- Visual and auditory problems,
- Injection of botulinum toxin in the last 6 months,
- History of surgical operation such as muscle relaxation, tendon extension and selective dorsal rhizotomy in the last 6 months.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Control Group
Study Group
Participants in this group will receive only Neurodevelopmental therapy (NDT) based rehabilitation for 45 minutes in each session, twice a week, during 8 weeks, 16 sessions in total. Number of participants in this group is anticipated to be 20.
After 16 sessions (8 weeks) of only Neurodevelopmental therapy (NDT) based rehabilitation, simulated hippotherapy treatment will be added to rehabilitation program of the same participants. Their NDT treatment will be reduced to 25 minutes whereas hippotherapy will be applied for 20 minutes in each session, 2 sessions a week, 8 weeks in total.